NO20024708D0 - Behandling av respiratoriske sykdommer - Google Patents

Behandling av respiratoriske sykdommer

Info

Publication number: NO20024708D0
Authority: NO; Norway
Prior art keywords: treatment; respiratory diseases; glycopyrrolate; dry powder; formulation
Prior art date: 2000-04-07

Application number

NO20024708A

Other languages

English (en)

Other versions

NO20024708L (no

NO336142B1 (no

Inventor

Robin Mark Bannister

Andrew John Mcglashan Richards

Julian Clive Gilbert

David Alexander Vodden Morton

John Nicholas Staniforth

Original Assignee

Arakis Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-07

Filing date

2002-10-01

Publication date

2002-10-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9889490&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20024708(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-10-01 Application filed by Arakis Ltd filed Critical Arakis Ltd

2002-10-01 Publication of NO20024708D0 publication Critical patent/NO20024708D0/no

2002-10-24 Publication of NO20024708L publication Critical patent/NO20024708L/no

2015-05-26 Publication of NO336142B1 publication Critical patent/NO336142B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Detergent Compositions (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)

NO20024708A 2000-04-07 2002-10-01 Farmasøytisk preparat omfattende glykopyrrolat, tørrpulverinhalator som omfatter preparatet og anvendelse derav NO336142B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0008660.3A GB0008660D0 (en)	2000-04-07	2000-04-07	The treatment of respiratory diseases
PCT/GB2001/001606 WO2001076575A2 (en)	2000-04-07	2001-04-09	The treatment of respiratory diseases

Publications (3)

Publication Number	Publication Date
NO20024708D0 true NO20024708D0 (no)	2002-10-01
NO20024708L NO20024708L (no)	2002-10-24
NO336142B1 NO336142B1 (no)	2015-05-26

Family

ID=9889490

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO20024708A NO336142B1 (no)	2000-04-07	2002-10-01	Farmasøytisk preparat omfattende glykopyrrolat, tørrpulverinhalator som omfatter preparatet og anvendelse derav
NO2015025C NO2015025I1 (no)	2000-04-07	2015-11-25	Beta2-agonist, spesielt indakaterol maleat og glykopyrronium eller salt derav, spesielt glykopyrroniumbromid
NO2015024C NO2015024I2 (no)	2000-04-07	2015-11-25	glykopyrronium eller et salt derav

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
NO2015025C NO2015025I1 (no)	2000-04-07	2015-11-25	Beta2-agonist, spesielt indakaterol maleat og glykopyrronium eller salt derav, spesielt glykopyrroniumbromid
NO2015024C NO2015024I2 (no)	2000-04-07	2015-11-25	glykopyrronium eller et salt derav

Country Status (25)

Country	Link
US (3)	US7229607B2 (no)
EP (3)	EP2193791A1 (no)
JP (1)	JP5042426B2 (no)
CN (3)	CN1292745C (no)
AT (1)	ATE330585T2 (no)
AU (2)	AU2004242450B2 (no)
BE (1)	BE2013C023I2 (no)
BR (1)	BR0109875A (no)
CA (1)	CA2405705C (no)
CY (1)	CY1105120T1 (no)
DE (1)	DE60120936T3 (no)
DK (1)	DK1267866T4 (no)
ES (2)	ES2266242T5 (no)
GB (1)	GB0008660D0 (no)
HK (1)	HK1050846B (no)
HU (2)	HU230958B1 (no)
IL (2)	IL151791A0 (no)
LU (2)	LU92166I2 (no)
MX (1)	MXPA02009718A (no)
NO (3)	NO336142B1 (no)
NZ (2)	NZ521476A (no)
PL (1)	PL364024A1 (no)
PT (1)	PT1267866E (no)
WO (1)	WO2001076575A2 (no)
ZA (1)	ZA200207420B (no)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0008660D0 (en) *	2000-04-07	2000-05-31	Arakis Ltd	The treatment of respiratory diseases
PT1337239E (pt)	2000-11-30	2010-01-26	Vectura Ltd	Partículas servindo à preparação de uma composição farmacêutica
ES2708961T3 (es)	2000-11-30	2019-04-12	Vectura Ltd	Composiciones farmacéuticas para inhalación
US20050130990A1 (en) *	2001-03-23	2005-06-16	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
CA2341952A1 (en)	2001-03-23	2002-09-23	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
KR20040007596A (ko)	2001-05-23	2004-01-24	다나베 세이야꾸 가부시키가이샤	골절 치료 촉진용 조성물
US20040180900A1 (en)	2001-05-23	2004-09-16	Masaharu Takigawa	Therapeutic composition for repairing chondropathy
RS52387B (sr) *	2002-03-01	2013-02-28	Chiesi Farmaceutici S.P.A.	Formoterol najfiniji preparat
US8039459B2 (en)	2004-07-15	2011-10-18	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
US8557804B2 (en)	2002-03-25	2013-10-15	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
US20040121003A1 (en) *	2002-12-19	2004-06-24	Acusphere, Inc.	Methods for making pharmaceutical formulations comprising deagglomerated microparticles
EP2287326A1 (en) *	2003-08-08	2011-02-23	Arriva Pharmaceuticals, Inc.	Methods of protein production in yeast
GB0327723D0 (en) *	2003-09-15	2003-12-31	Vectura Ltd	Pharmaceutical compositions
SI1684719T1 (sl) *	2003-11-14	2012-07-31	Baxter Int	Sestavki alfa antitripsina in postopki zdravljenja ob uporabi takih sestavkov
CA2550841C (en) *	2004-02-06	2012-10-02	Meda Pharma Gmbh & Co. Kg	Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases
EP1713472A2 (en) *	2004-02-06	2006-10-25	MEDA Pharma GmbH & Co. KG	Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
WO2005074982A2 (en) *	2004-02-06	2005-08-18	Meda Pharma Gmbh & Co. Kg	Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
ES2413011T3 (es)	2004-02-06	2013-07-15	Meda Pharma Gmbh & Co. Kg	Combinación de anticolinérgicos y glucocorticoides para el tratamiento a largo plazo de asma y EPOC
EP1720577A2 (en) *	2004-02-27	2006-11-15	Altana Pharma AG	Ciclesonide and glycopyrronium combination
CA2559062A1 (en) *	2004-03-09	2005-09-22	Arriva Pharmaceuticals, Inc.	Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
GB0409703D0 (en) *	2004-04-30	2004-06-02	Vectura Ltd	Pharmaceutical compositions
GB0410398D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
GB0410399D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
EP1763344A1 (en) *	2004-06-29	2007-03-21	Boehringer Ingelheim International GmbH	Medicaments for inhalation comprising steroids and an anticholinergic
EP1616567A1 (en) *	2004-07-16	2006-01-18	Boehringer Ingelheim Pharma GmbH & Co.KG	Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts
JP2008511637A (ja)	2004-08-27	2008-04-17	ザダウケミカルカンパニー	致命的な感染症を治療する薬剤組成物の増強された供給
US20070105768A1 (en) *	2004-11-10	2007-05-10	Rajiv Nayar	Dry recombinant human alpha 1-antitrypsin formulation
GB0425758D0 (en)	2004-11-23	2004-12-22	Vectura Ltd	Preparation of pharmaceutical compositions
WO2006087919A1 (ja) *	2005-01-28	2006-08-24	Takeda Pharmaceutical Company Limited	難水溶性物質含有微細化組成物
AU2006224842B2 (en)	2005-03-16	2011-09-29	Meda Pharma Gmbh & Co Kg	The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
US7915303B2 (en) *	2005-03-24	2011-03-29	Sosei R&D Ltd.	Glycopyrronium salts and their therapeutic use
JP2009519970A (ja) *	2005-12-15	2009-05-21	アキュスフィア，インコーポレイテッド	粒子ベースの経口投与用製薬剤形の製造方法
ES2330047T3 (es) *	2005-12-21	2009-12-03	MEDA PHARMA GMBH & CO. KG	Combinacion de r,r-glicopirrolato, rolipram y budesonida para el tratmiento de enfermedades inflamatorias.
GB2434098A (en) *	2005-12-23	2007-07-18	Novartis Ag	Process for the preparation of an inhalable dry powder formulation
US20090062326A1 (en) *	2006-03-17	2009-03-05	Spindel Eliot R	M3 muscarinic receptor antagonists for treatment of m3 muscarinic receptor-expressing tumors
GB0613161D0 (en) *	2006-06-30	2006-08-09	Novartis Ag	Organic Compounds
KR20100099281A (ko) *	2007-12-13	2010-09-10	노파르티스 아게	유기 화합물
ES2460576T3 (es) *	2007-12-13	2014-05-13	Novartis Ag	Procedimiento para preparar una sustancia farmacológica en partículas y cristalina
US20090215734A1 (en) *	2008-02-26	2009-08-27	Elevation Pharmaceuticals, Inc.	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
US20100055045A1 (en) *	2008-02-26	2010-03-04	William Gerhart	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
PT3578169T (pt)	2009-02-26	2024-07-29	Glaxo Group Ltd	Formulações farmacêuticas compreendendo 4-{(1r)-2-[(2,6- diclorobenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2- (hidroximetil)fenol
KR20120015334A (ko)	2009-05-29	2012-02-21	펄 테라퓨틱스 인코포레이티드	활성제의 호흡기 전달용 조성물, 및 연관된 방법 및 시스템
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
GB0921075D0 (en)	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
PE20121467A1 (es)	2009-12-23	2012-11-07	Chiesi Farma Spa	Formulacion de aerosol para la enfermedad pulmonar obstructiva cronica
BR112012015334A2 (pt)	2009-12-23	2016-03-15	Chiesi Farma Spa	terapia combinada para doença pulmonar obstrutiva crônica
CA2785347C (en)	2009-12-23	2018-02-27	Chiesi Farmaceutici S.P.A.	Aerosol formulation for copd
PE20121396A1 (es)	2009-12-23	2012-10-24	Chiesi Farma Spa	Composicion farmaceutica que comprende bromuro de glicopirronio y formoterol
CN107096014B (zh)	2010-09-29	2022-07-15	普马特里克斯营业公司	吸入用单价金属阳离子干粉剂
JOP20120023B1 (ar)	2011-02-04	2022-03-14	Novartis Ag	صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
PT2739268T (pt)	2011-08-01	2019-01-28	Univ Monash	Método e formulação para inalação
CN107596518B (zh)	2012-02-29	2021-04-23	普马特里克斯营业公司	可吸入干粉剂
EP2968152B2 (en)	2013-03-15	2022-06-22	Pearl Therapeutics, Inc.	Methods and systems for conditioning of particulate crystalline materials
AU2014248455B2 (en)	2013-04-01	2018-12-06	Pulmatrix Operating Company, Inc.	Tiotropium dry powders
US9393202B2 (en) *	2013-04-26	2016-07-19	Chiesi Farmaceutici S.P.A	Particle size reduction of an antimuscarinic compound
US20160317391A1 (en) *	2013-12-17	2016-11-03	Merck Sharp & Dohme Corp.	Media milling process for the manufacture of active pharmaceutical ingredients in propellants
SI3089735T1 (sl)	2013-12-30	2018-10-30	Chiesi Farmaceutici S.P.A.	Sestavek stabilne aerosolne raztopine pod tlakom, ki vsebuje glikopironijev bromid in formoterol
MA50680A (fr)	2014-09-09	2020-08-05	Vectura Ltd	Formulation comprenant glycopyrrolate, procédé et appareil
SMT201900340T1 (it) *	2014-09-15	2019-07-11	Verona Pharma Plc	Formulazione liquida per l’inalazione comprendente rpl554
MA41378A (fr) *	2015-01-20	2017-11-28	Teva Branded Pharmaceutical Prod R & D Inc	Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol
WO2016170518A1 (en)	2015-04-24	2016-10-27	Glenmark Specialty S.A.	Pharmaceutical compositions comprising arformoterol and glycopyrronium
MX389992B (es) *	2015-06-15	2025-03-20	Qaam Pharmaceuticals Llc	Sales de ácido graso de glicopirronio y métodos para elaborar las mismas
US9925168B2 (en) *	2016-01-22	2018-03-27	Chiesi Farmaceutici S.P.A.	Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
US10098837B2 (en)	2016-07-28	2018-10-16	Chiesi Farmaceutici S.P.A.	Combination therapy for COPD
CN114502146A (zh)	2019-12-02	2022-05-13	奇斯药制品公司	用于加压定量吸入器的不锈钢罐

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3400197A (en)	1965-01-26	1968-09-03	Robins Co Inc A H	Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US5376386A (en) *	1990-01-24	1994-12-27	British Technology Group Limited	Aerosol carriers
US5849263A (en) *	1993-03-30	1998-12-15	Charlotte-Mecklenburg Hospital Authority	Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
TW402506B (en) *	1993-06-24	2000-08-21	Astra Ab	Therapeutic preparation for inhalation
DE4425255A1 (de) *	1994-07-16	1996-01-18	Asta Medica Ag	Formulierung zur inhalativen Applikation
SA95160463B1 (ar) *	1994-12-22	2005-10-04	استرا أكتيبولاج	مساحيق للاستنشاق
US5612053A (en) *	1995-04-07	1997-03-18	Edward Mendell Co., Inc.	Controlled release insufflation carrier for medicaments
US5690374A (en) *	1996-04-19	1997-11-25	Nor-Easter Enterprises, Inc.	Shock-absorbing tool handle
US6613795B2 (en) *	1996-11-11	2003-09-02	Christian Noe	Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
DK1371645T3 (da) *	1996-11-11	2013-06-03	Meda Pharma Gmbh & Co Kg	Anvendelse af (3S,2'R)-glycopyrronium som lægemiddel
CA2277801C (en) *	1997-01-16	2002-10-15	Massachusetts Institute Of Technology	Preparation of particles for inhalation
SE9700133D0 (sv) *	1997-01-20	1997-01-20	Astra Ab	New formulation
US6461591B1 (en) *	1997-02-05	2002-10-08	Jago Research Ag	Medical aerosol formulations
US6495167B2 (en) *	1997-03-20	2002-12-17	Schering Corporation	Preparation of powder agglomerates
AU748867B2 (en) *	1998-07-24	2002-06-13	Jagotec Ag	Medicinal aerosol formulations
CA2338680C (en) *	1998-08-04	2008-10-14	Jago Research Ag	Medicinal aerosol formulations
ES2192866T3 (es) *	1998-11-13	2003-10-16	Jago Res Ag	Polvo seco para inhalacion.
US6406745B1 (en) *	1999-06-07	2002-06-18	Nanosphere, Inc.	Methods for coating particles and particles produced thereby
AU7389300A (en) *	1999-08-02	2001-02-19	First Horizon Pharmaceutical Corporation	Methods of administration of glycopyrrolate compositions
GB0008660D0 (en)	2000-04-07	2000-05-31	Arakis Ltd	The treatment of respiratory diseases
US6758795B2 (en) *	2000-08-22	2004-07-06	Stephen Barber	Adjustable water-fillable exercise weights
GB0029903D0 (en) *	2000-12-07	2001-01-24	Arakis Ltd	Use of anti-muscarinic agents
GB0410399D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
GB0410398D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
TWI509631B (zh)	2011-02-25	2015-11-21	漢高智慧財產控股公司	用於電子裝置之可燒結銀薄片黏著劑

2000
- 2000-04-07 GB GBGB0008660.3A patent/GB0008660D0/en not_active Ceased
2001
- 2001-04-09 EP EP10153877A patent/EP2193791A1/en not_active Withdrawn
- 2001-04-09 NZ NZ521476A patent/NZ521476A/en not_active IP Right Cessation
- 2001-04-09 CN CNB018075584A patent/CN1292745C/zh not_active Expired - Lifetime
- 2001-04-09 MX MXPA02009718A patent/MXPA02009718A/es active IP Right Grant
- 2001-04-09 DE DE60120936.2T patent/DE60120936T3/de not_active Expired - Lifetime
- 2001-04-09 EP EP01966751.8A patent/EP1267866B2/en not_active Expired - Lifetime
- 2001-04-09 BR BR0109875-6A patent/BR0109875A/pt not_active Application Discontinuation
- 2001-04-09 CN CNA200510076362XA patent/CN1720995A/zh active Pending
- 2001-04-09 IL IL15179101A patent/IL151791A0/xx unknown
- 2001-04-09 NZ NZ535284A patent/NZ535284A/xx not_active IP Right Cessation
- 2001-04-09 AT AT01966751T patent/ATE330585T2/de active
- 2001-04-09 CA CA2405705A patent/CA2405705C/en not_active Expired - Lifetime
- 2001-04-09 HK HK03101991.4A patent/HK1050846B/en unknown
- 2001-04-09 HU HU0301518A patent/HU230958B1/hu active Protection Beyond IP Right Term
- 2001-04-09 WO PCT/GB2001/001606 patent/WO2001076575A2/en not_active Ceased
- 2001-04-09 PT PT01966751T patent/PT1267866E/pt unknown
- 2001-04-09 ES ES01966751.8T patent/ES2266242T5/es not_active Expired - Lifetime
- 2001-04-09 CN CN2007101471670A patent/CN101181263B/zh not_active Expired - Lifetime
- 2001-04-09 DK DK01966751.8T patent/DK1267866T4/en active
- 2001-04-09 EP EP04011047.0A patent/EP1449528B1/en not_active Expired - Lifetime
- 2001-04-09 PL PL01364024A patent/PL364024A1/xx not_active Application Discontinuation
- 2001-04-09 ES ES04011047.0T patent/ES2687751T3/es not_active Expired - Lifetime
- 2001-04-09 JP JP2001574093A patent/JP5042426B2/ja not_active Expired - Lifetime
2002
- 2002-09-16 ZA ZA200207420A patent/ZA200207420B/en unknown
- 2002-09-18 IL IL151791A patent/IL151791A/en active IP Right Grant
- 2002-10-01 NO NO20024708A patent/NO336142B1/no not_active IP Right Cessation
- 2002-10-07 US US10/266,717 patent/US7229607B2/en not_active Expired - Lifetime
2004
- 2004-08-24 US US10/926,196 patent/US7368104B2/en not_active Expired - Lifetime
- 2004-12-22 AU AU2004242450A patent/AU2004242450B2/en not_active Expired
2006
- 2006-07-31 CY CY20061101079T patent/CY1105120T1/el unknown
2008
- 2008-03-14 US US12/048,812 patent/US8029768B2/en not_active Expired - Lifetime
2010
- 2010-02-23 AU AU2010200660A patent/AU2010200660B2/en active Active
2013
- 2013-03-13 LU LU92166C patent/LU92166I2/fr unknown
- 2013-03-26 BE BE2013C023C patent/BE2013C023I2/fr unknown
2014
- 2014-03-07 LU LU92393C patent/LU92393I2/xx unknown
2015
- 2015-11-25 NO NO2015025C patent/NO2015025I1/no not_active Application Discontinuation
- 2015-11-25 NO NO2015024C patent/NO2015024I2/no not_active IP Right Cessation
2019
- 2019-12-23 HU HUS1900056C patent/HUS1900056I1/hu unknown

Also Published As

Publication number	Publication date
NO2015024I1 (no)	2015-11-25
DE60120936T3 (de)	2016-11-17
MXPA02009718A (es)	2003-05-27
ES2266242T3 (es)	2007-03-01
IL151791A0 (en)	2003-04-10
ES2687751T3 (es)	2018-10-29
US8029768B2 (en)	2011-10-04
CA2405705A1 (en)	2001-10-18
HUS1900056I1 (hu)	2020-02-28
BR0109875A (pt)	2004-07-20
PL364024A1 (en)	2004-11-29
EP1267866B2 (en)	2016-07-20
DE60120936T2 (de)	2006-11-02
HK1050846B (en)	2007-01-26
US20080220073A1 (en)	2008-09-11
EP1267866A2 (en)	2003-01-02
BE2013C023I2 (no)	2020-06-24
GB0008660D0 (en)	2000-05-31
DE60120936D1 (de)	2006-08-03
IL151791A (en)	2015-05-31
CA2405705C (en)	2011-06-07
ZA200207420B (en)	2003-09-16
AU2004242450A1 (en)	2005-01-20
NO20024708L (no)	2002-10-24
NO2015024I2 (no)	2015-11-25
EP2193791A1 (en)	2010-06-09
DK1267866T4 (en)	2016-10-03
HK1050846A1 (en)	2003-07-11
ES2266242T5 (es)	2016-10-04
US7229607B2 (en)	2007-06-12
JP2003530344A (ja)	2003-10-14
JP5042426B2 (ja)	2012-10-03
US20030068280A1 (en)	2003-04-10
EP1449528A1 (en)	2004-08-25
NO336142B1 (no)	2015-05-26
US7368104B2 (en)	2008-05-06
NZ521476A (en)	2004-10-29
CN1720995A (zh)	2006-01-18
NO2015025I1 (no)	2015-12-07
AU8930601A (en)	2001-10-23
CN1292745C (zh)	2007-01-03
LU92166I2 (fr)	2014-03-13
CN101181263B (zh)	2011-07-06
AU776913B2 (en)	2004-09-23
CY1105120T1 (el)	2010-03-03
US20050019271A1 (en)	2005-01-27
HU230958B1 (hu)	2019-06-28
NZ535284A (en)	2006-04-28
WO2001076575A2 (en)	2001-10-18
AU2010200660A1 (en)	2010-03-11
WO2001076575A3 (en)	2002-03-28
HUP0301518A2 (hu)	2003-08-28
DK1267866T3 (da)	2006-10-23
LU92393I2 (fr)	2015-11-02
EP1267866B1 (en)	2006-06-21
AU2010200660B2 (en)	2012-04-19
CN101181263A (zh)	2008-05-21
ATE330585T2 (de)	2006-07-15
EP1449528B1 (en)	2018-08-08
PT1267866E (pt)	2006-10-31
AU2004242450B2 (en)	2010-06-03
CN1422154A (zh)	2003-06-04

Publication	Publication Date	Title
NO20024708D0 (no)	2002-10-01	Behandling av respiratoriske sykdommer
MXPA02011311A (es)	2003-04-25	Composicion novedosa.
IL167900A (en)	2013-06-27	Use of betamimetics to prepare a medical preparation for the treatment of chronic obstructive pulmonary disease
ATE330589T1 (de)	2006-07-15	Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
CL2003002746A1 (es)	2005-02-11	Compuesto derivado de piridazin-3(2h)-ona sustituida en las posiciones 4,5,6; procedimiento de preparacion de dicho compuesto; compuesto intermediario; composicion farmaceutica; y el uso del compuesto para el tratamiento del asma, enfermedad pulmonar
NO20071577L (no)	2007-05-02	Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
BR0015908A (pt)	2002-08-06	Emprego de compostos org nicos no tratamento de doenças
NO20061254L (no)	2006-04-11	Farmasoytiske blandinger
YU36302A (sh)	2002-09-19	Novi tiotropiumski preparati - koji sadrže prah za inhaliranje
YU71901A (sh)	2005-07-19	NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
ATE361077T1 (de)	2007-05-15	Indanylderivate zur behandlung von atemwegserkrankungen
DE60120648D1 (de)	2006-07-27	Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
NO20025220L (no)	2002-10-31	Ny fremgangsmåte
ATE479433T1 (de)	2010-09-15	Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
WO2005011614A8 (en)	2005-05-19	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
WO2002017894A3 (en)	2002-08-08	Pharmaceutical formulation of salmeterol and fluticasone propionate
UY30935A1 (es)	2008-09-30	Combinacion:-antagonista del receptor de quimioquina 1 (ccr1) -agonista del receptor de glucocorticoides- opcionalmente agonista b(beta)2, -composicion farmacéutica conteniéndola -aplicaciones.
SG137859A1 (en)	2007-12-28	Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
WO2005011604A3 (en)	2009-03-26	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
HRP20100208T8 (hr)	2010-06-30	Postupak liječenja akutnog rinosinusitisa
WO2005011595A3 (en)	2007-08-02	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
WO2005011602A3 (en)	2007-05-03	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
WO2005011616A3 (en)	2007-02-22	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
EA200500864A1 (ru)	2006-02-24	Новый, содержащий тиотропий порошковый препарат для ингаляции
MXPA04007294A (es)	2004-10-29	Composicion para inhalacion.

Legal Events

Date	Code	Title	Description
2017-01-16	SPCG	Granted supplementary protection certificate	Free format text: PRODUCT NAME: GLYKOPYRRONIUM ELLER ET SALT DERAV; REG. NO/DATE: EU/1/12/788/001-006 20121017 Spc suppl protection certif: 2015024 Filing date: 20151125 Extension date: 20260409
2019-05-06	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: HEPTARES THERAPEUTICS LIMITED, GB
2019-05-06	SPCS	Change of name or address of the owner of a supplementary protection certificate
2021-05-10	MK1K	Patent expired
2021-11-29	SPCU	Supplementary protection certificate (spc) lapsed by not paying the annual fees	Spc suppl protection certif: 2015024 Effective date: 20211118